BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shetty A, Wilson S, Kuo P, Laurin JL, Howell CD, Johnson L, Allen EM. Liver transplantation improves cirrhosis-associated impaired oral glucose tolerance. Transplantation 2000;69:2451-4. [PMID: 10868659 DOI: 10.1097/00007890-200006150-00043] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Kumar R, García-Compeán D, Maji T. Hepatogenous diabetes: Knowledge, evidence, and skepticism. World J Hepatol 2022;14:1291-306. [PMID: 36158904 DOI: 10.4254/wjh.v14.i7.1291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Zhao M, Yang S, Su X, Hung T, Liu Y, Zheng W. Hepatitis B Virus Infection and Increased Risk of Gestational Diabetes Regardless of Liver Function Status: A Xiamen Area Population-Based Study. Front Physiol 2022;13:938149. [DOI: 10.3389/fphys.2022.938149] [Reference Citation Analysis]
3 Gundling F. Der hepatogene Diabetes – aktueller Stand der Diagnostik und Therapie. J Klin Endokrinol Stoffw 2022;15:42-52. [DOI: 10.1007/s41969-022-00158-z] [Reference Citation Analysis]
4 García-Compeán D, Orsi E, Kumar R, Gundling F, Nishida T, Villarreal-Pérez JZ, Del Cueto-Aguilera ÁN, González-González JA, Pugliese G. Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives. World J Gastroenterol 2022; 28(8): 775-793 [DOI: 10.3748/wjg.v28.i8.775] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Li C, Zhang W, Zhao Q, Ye M, Ju W, Wu L, Ma Y, Hu A, Wang G, Zhu X, Guo Z, Wang D, He X. Outcomes of Combined Liver and Pancreas Transplantation: A Review of the SRTR National Database and a Report of the Largest Single Center Series. Front Med (Lausanne) 2020;7:542905. [PMID: 33195293 DOI: 10.3389/fmed.2020.542905] [Reference Citation Analysis]
6 Infante M, Padilla N, Madiraju S, Alvarez A, Baidal D, Ricordi C, Alejandro R. Combined liver and islet transplantation in hepatogenous diabetes, cluster exenteration, and cirrhosis with type 1 diabetes. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas 2020. [DOI: 10.1016/b978-0-12-814833-4.00037-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Sehrawat T, Jindal A, Kohli P, Thour A, Kaur J, Sachdev A, Gupta Y. Utility and Limitations of Glycated Hemoglobin (HbA1c) in Patients with Liver Cirrhosis as Compared with Oral Glucose Tolerance Test for Diagnosis of Diabetes. Diabetes Ther 2018;9:243-51. [PMID: 29305791 DOI: 10.1007/s13300-017-0362-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
8 Kumar R. Hepatogenous Diabetes: An Underestimated Problem of Liver Cirrhosis. Indian J Endocrinol Metab. 2018;22:552-559. [PMID: 30148106 DOI: 10.4103/ijem.ijem_79_18] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
9 Silva TE, Ronsoni MF, Schiavon LL. Challenges in diagnosing and monitoring diabetes in patients with chronic liver diseases. Diabetes Metab Syndr. 2018;12:431-440. [PMID: 29279271 DOI: 10.1016/j.dsx.2017.12.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
10 Orsi E, Grancini V, Menini S, Aghemo A, Pugliese G. Hepatogenous diabetes: Is it time to separate it from type 2 diabetes? Liver Int 2017;37:950-62. [PMID: 27943508 DOI: 10.1111/liv.13337] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 7.2] [Reference Citation Analysis]
11 Rahimi Naini S, Fuchs M. Non-alcoholic fatty liver disease in patients with diabetes mellitus. Expert Rev Endocrinol Metab 2014;9:503-14. [PMID: 30736212 DOI: 10.1586/17446651.2014.938053] [Reference Citation Analysis]
12 Ahmadieh H, Azar ST. Liver disease and diabetes: association, pathophysiology, and management. Diabetes Res Clin Pract. 2014;104:53-62. [PMID: 24485856 DOI: 10.1016/j.diabres.2014.01.003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 6.2] [Reference Citation Analysis]
13 Loria P, Marchesini G, Nascimbeni F, Ballestri S, Maurantonio M, Carubbi F, Ratziu V, Lonardo A. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. Atherosclerosis 2014;232:99-109. [DOI: 10.1016/j.atherosclerosis.2013.10.030] [Cited by in Crossref: 88] [Cited by in F6Publishing: 83] [Article Influence: 9.8] [Reference Citation Analysis]
14 Gundling F, Schepp W. Diabetes und Leberzirrhose. Diabetologe 2013;9:541-550. [DOI: 10.1007/s11428-013-1067-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Gundling F, Seidl H, Strassen I, Haller B, Siegmund T, Umgelter A, Pehl C, Schepp W, Schumm-Draeger PM. Clinical manifestations and treatment options in patients with cirrhosis and diabetes mellitus. Digestion 2013;87:75-84. [PMID: 23306648 DOI: 10.1159/000343458] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
16 Khan R, Foster GR, Chowdhury TA. Managing diabetes in patients with chronic liver disease. Postgrad Med. 2012;124:130-137. [PMID: 22913901 DOI: 10.3810/pgm.2012.07.2574] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
17 Christiansen R, Melholt Rasmussen L, Nybo H, Steenstrup T, Nybo M. The relationship between HbA1c and fasting plasma glucose in patients with increased plasma liver enzyme measurements: Liver enzyme measurements and HbA1c. Diabetic Medicine 2012;29:742-7. [DOI: 10.1111/j.1464-5491.2011.03543.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
18 Bell DS, Allbright E. The multifaceted associations of hepatobiliary disease and diabetes. Endocr Pract 2007;13:300-12. [PMID: 17599864 DOI: 10.4158/EP.13.3.300] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
19 Stockmann M, Nolting S, Konrad T, Hünerbein D, Döbling H, Steinmüller T, Neuhaus P. No influence of immunosuppression on insulin sensitivity and beta-cell function in living donor liver transplantation. Transplant Proc 2005;37:1861-4. [PMID: 15919486 DOI: 10.1016/j.transproceed.2005.02.093] [Reference Citation Analysis]
20 Pirenne J, Deloose K, Coosemans W, Aerts R, Van Gelder F, Kuypers D, Maes B, Verslype C, Yap P, Van Steenbergen W, Roskams T, Mathieu C, Fevery J, Nevens F. Combined 'en bloc' liver and pancreas transplantation in patients with liver disease and type 1 diabetes mellitus. Am J Transplant 2004;4:1921-7. [PMID: 15476496 DOI: 10.1111/j.1600-6143.2004.00588.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
21 Lahousen T, Hegenbarth K, Ille R, Lipp RW, Krause R, Little RR, Schnedl WJ. Determination of glycated hemoglobin in patients with advanced liver disease. World J Gastroenterol 2004; 10(15): 2284-2286 [PMID: 15259084 DOI: 10.3748/wjg.v10.i15.2284] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
22 Albright ES, Bell DSH. The Liver, Liver Disease, and Diabetes Mellitus: . The Endocrinologist 2003;13:58-66. [DOI: 10.1097/00019616-200301000-00011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]